Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MOR | MRUS | KYMR | ||
| Company | Morphosys Ag ADR | Merus N.V. CS | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.38 | 50.32 | 48.34 | ||
| High | 19.15 | 51.10 | 50.69 | ||
| Low | 18.38 | 49.47 | 47.56 | ||
| Last | 18.96 | 50.81 | 49.03 | ||
| Change | +0.45 | +1.39 | +2.59 | ||
| % Change | +2.43% | +2.81% | +5.58% | ||
| Volume | 19,100 | 1,144,100 | 484,500 | ||
| 20-Day Average Volume | 25,605 | 479,280 | 354,195 | ||
| Previous Close | 18.51 | 49.42 | 46.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.58 | 50.91 | 47.09 | ||
| 20-Day Raw Stochastic | 81.19% | 41.35% | 75.55% | ||
| 20-Day Relative Strength | 57.86% | 47.77% | 58.30% | ||
| Weighted Alpha | +39.78 | +64.99 | +100.31 | ||
| Today's Opinion | 100% Buy | 8% Buy | 100% Buy | ||
| Previous Opinion | 88% Buy | 8% Sell | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.99% since 07/26/24 | +3.40% since 09/12/24 | +9.64% since 09/12/24 | ||
| Low | 18.32 on 07/29/24 | 48.78 on 09/18/24 | 44.53 on 09/13/24 | ||
| High | 19.15 on 08/02/24 | 51.34 on 09/18/24 | 50.69 on 09/19/24 | ||
| 1-Month | |||||
| %Chg | +4.75% since 07/02/24 | -5.35% since 08/19/24 | +10.06% since 08/19/24 | ||
| Low | 18.08 on 07/03/24 | 48.12 on 09/06/24 | 43.90 on 09/06/24 | ||
| High | 19.15 on 08/02/24 | 54.63 on 08/23/24 | 50.69 on 09/19/24 | ||
| 3-Month | |||||
| %Chg | +6.10% since 05/02/24 | -6.32% since 06/18/24 | +57.15% since 06/18/24 | ||
| Low | 17.80 on 05/03/24 | 47.50 on 08/05/24 | 29.24 on 06/28/24 | ||
| High | 19.50 on 05/16/24 | 61.28 on 06/28/24 | 50.69 on 09/19/24 | ||
| 6-Month | |||||
| %Chg | +71.27% since 02/02/24 | +12.89% since 03/19/24 | +23.91% since 03/19/24 | ||
| Low | 11.06 on 02/05/24 | 39.27 on 04/19/24 | 29.24 on 06/28/24 | ||
| High | 19.50 on 05/16/24 | 61.61 on 05/24/24 | 50.69 on 09/19/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,855,774 | 2,900,360 | 2,849,466 | ||
| Shares Outstanding, K | 150,621 | 58,688 | 61,358 | ||
| Annual Sales | 257,890,000 | 43,950,000 | 78,590,000 | ||
| Annual Net Income | -205,350,000 | -154,940,000 | -146,960,000 | ||
| Last Quarter Sales | 29,900,000 | 7,330,000 | 25,650,000 | ||
| Last Quarter Net Income | -341,960,000 | -50,040,000 | -42,060,000 | ||
| 60-Month Beta | 1.20 | 1.12 | 2.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.24 on 04/29/24 | -0.81 on 08/01/24 | -0.58 on 08/07/24 | ||
| Latest Earnings Date | 08/29/24 | 11/07/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||